CA
NZ
UK
AU
IND
US
● Scribe Therapeutics shares have risen to $37.25, up 9.14%, onVolumerunning about 2.5 times its recent average, extending a remarkable post-IPO run.
● Picard Medical shares have staged a dramatic rebound, most recently closing at $5.13, up 59.81%, on relativeVolumeof roughly 22 times normal, reversing a sharp mid-month slide that had dragged the stock toward $3.
● QT Imaging shares have advanced to close at $3.31, up 13.75%, on relativeVolumeof roughly 1.6 times its recent average, extending momentum built through a strong August of updates.
● Anbio Biotechnology shares have added to recent gains, closing near $7.90, up 16.01%, with relativeVolumeonly modestly elevated at around 1.48.
● Nutriband shares have surged to $5.11, up 9.51%, with relative turnover hitting 20.2 times normal on roughly 257,000 shares, an extraordinary spike for a company whose daily trading is usually sleepy.
● OmniAb shares have risen to $4.71, up 8.78%, on relativeVolumeof just 0.57, below the stock's average.
● Generate Biomedicines shares have extended a strong late-summer run, climbing to $17.72, up 9.93%, onVolumeof roughly 2.5 million shares running about 3.5 times its recent norm.
● Faeth Therapeutics shares have climbed to $34.71, up 8.47%, without a discrete, company-issued announcement identified to explain the single-day gain.
● EUDA Health Holdings shares have risen to about $15.40, up 16.58%, on fewer than 10,000 shares traded, aVolumelevel at which a handful of orders can produce a large percentage move.
● Devoted Health issued aMedicareAdvantage coverage policy for Barostim, covering patients who meet FDA-approved indications as well as those enrolled in a related clinical trial, the second major insurer to adopt such a policy.
Please wait processing your request...